{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"49.9","upperLimit":"70.8","value":"61.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"}],"units":"Participants"}],"description":"Patients were evaluated for event free survival (EFS) throughout the study. Events were defined as death, relapse, progression, or nonengraftment. Kaplan Meier estimates were calculated as time from HSCT to event.","dispersionType":"95% Confidence Interval","groups":[{"description":"All patients were analyzed as a single population. Stratification by conditioning regimen was not done.","id":"OG000","title":"All Patients"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"2 year point estimate was provided.","title":"Event Free Survival at Two Years Post HSCT","type":"SECONDARY","unitOfMeasure":"Percentage of patients with an event"}